XEFO 8mg / 2ml powder + solvent for injection medication leaflet

M01AC05 lornoxicam • Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Oxicams

Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat acute and chronic pain, as well as inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or other musculoskeletal disorders. It is also used for the relief of postoperative or post-traumatic pain.

Lornoxicam works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing the production of prostaglandins, substances involved in inflammation, pain, and fever. It is available in tablet or injectable solution form.

Side effects may include nausea, stomach pain, diarrhea, dizziness, heartburn, or, in rare cases, gastric ulcers, gastrointestinal bleeding, or allergic reactions. Long-term use or high doses may increase the risk of cardiovascular events and kidney damage. It is important to take the medication as prescribed by a doctor, and patients with a history of gastric or cardiovascular conditions should be closely monitored.

General data about XEFO 8mg / 2ml

Substance: lornoxicam

Date of last drug list: 01-07-2020

Commercial code: W62179001

Concentration: 8mg / 2ml

Pharmaceutical form: powder + solvent for injection

Packing volume: 2ml

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: TAKEDA AUSTRIA GMBH - AUSTRIA

Holder: TAKEDA AUSTRIA GMBH - AUSTRIA

Number: 3731/2011/04

Shelf life: 3 years; after reconstitution-24h

Pharmaceutical forms available for lornoxicam

Concentrations available for lornoxicam

4mg, 8mg, 8mg/2ml

Other substances similar to lornoxicam